Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.1 USD | +3.72% | -8.03% | +114.32% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration- Stock Market
- Equities
- MGTA Stock
- News Magenta Therapeutics
- Magenta Therapeutics : B. Riley Lowers Magenta Therapeutics' PT to $19 from $21, Updates Model due to Potential Clinical Trial Delay; Keeps Buy Rating